Skip to main content
Medika d.d. logo

Medika d.d. — Investor Relations & Filings

Ticker · MDKA ISIN · HRMDKARA0000 LEI · 74780000O0R8ZVGJJO27 ZSE Wholesale and retail trade
Open in API
Filings indexed 891 across all filing types
Latest filing 2015-03-10 Financial Supplement Da…
Country HR Croatia
Listing ZSE MDKA

About Medika d.d.

https://www.medika.hr/en/

Medika d.d. is a pharmaceutical wholesale company specializing in the sale, storage, and distribution of products for the healthcare sector. The company's primary activities encompass the supply of a broad range of goods, including human and veterinary drugs, medical products, dental supplies, and various types of equipment. In addition to its core pharmaceutical distribution, Medika's portfolio also includes dietetic, cosmetic, and hygienic products. The company provides comprehensive logistics and distribution services to a diverse client base within the healthcare market.

Recent filings

Filing Released Lang Actions
GFI-POD Medika Grupa 31.12.2014.
Financial Supplement Data
2015-03-10 Croatian
Medika Grupa 2014.
Audit Report / Information Classification · 98% confidence The document title is "IZVJEŠĆE REVIZORA I KONSOLIDIRANI FINANCIJSKI IZVJEŠTAJI 31. PROSINCA 2014." (Auditor's Report and Consolidated Financial Statements as of December 31, 2014). The table of contents explicitly lists sections like 'Godišnje izvješće' (Annual Report), 'Izvješće neovisnog revizora dioničarima' (Independent Auditor's Report to Shareholders), and various consolidated financial statements (Statement of Comprehensive Income, Statement of Financial Position, etc.). The text contains the full 'Izvješće neovisnog revizora' (Independent Auditor's Report) and the 'Izjava o odgovornosti Uprave i Nadzornog odbora' (Statement of Responsibility of the Management Board and Supervisory Board), which are integral components of a comprehensive annual financial filing. Although it contains an auditor's report, the document is clearly structured as the full annual financial report for the year ended December 31, 2014, which aligns best with the definition of an Annual Report (10-K equivalent in structure, though this is a Croatian filing). Given the comprehensive nature, inclusion of the auditor's opinion, and the reference to the 'Godišnje izvješće' (Annual Report), the classification should be 10-K, as it represents the full annual financial disclosure. FY 2014
2015-03-10 Croatian
GFI-POD Medika 31.12.2014.
Financial Supplement Data
2015-03-10 Croatian
Medika d.d. 2014
Audit Report / Information Classification · 98% confidence The document is titled "IZVJEŠĆE REVIZORA I NEKONSOLIDIRANI FINANCIJSKI IZVJEŠTAJI 31. PROSINCA 2014." (Auditor's Report and Unconsolidated Financial Statements as of December 31, 2014). The table of contents explicitly lists the 'Godišnje izvješće' (Annual Report), 'Izvješće neovisnog revizora' (Independent Auditor's Report), and various financial statements (Statement of Comprehensive Income, Statement of Financial Position, etc.). The text contains the full 'Izjava o odgovornosti Uprave i Nadzornog odbora' (Statement of Responsibility of Management and Supervisory Board) and the detailed 'Izvješće neovisnog revizora' (Independent Auditor's Report) which expresses an opinion on the financial statements. Although it contains an auditor's report, the primary document structure and content strongly align with a comprehensive annual filing that includes both the management report/financials and the audit opinion. Given the inclusion of the full financial statements and the auditor's opinion for the full year, this is classified as the Annual Report (10-K equivalent in structure, though likely filed under local regulations, the closest fit for a comprehensive annual filing is 10-K or AR). Since it contains the full financial statements and the management's discussion/analysis (implied by the 'Godišnje izvješće' section), 10-K is the most appropriate category for a full annual filing, even if it also contains the AR component. If the document was *only* the auditor's opinion, AR would be better, but here the financial statements and annual report narrative are central. FY 2014
2015-03-10 Croatian
Obavijest o održanoj sjednici NO 10.03.2015
Earnings Release Classification · 99% confidence The document is a short announcement (1366 characters) written in Croatian ('OBAVIJEST' means 'NOTICE'). It reports key financial highlights for the period ending 31.12.2014 (annual results), including total revenue and net profit for both the standalone company and the consolidated group. It explicitly states that the Supervisory Board gave consent to the non-consolidated and consolidated financial statements for the period 01.01.-31.12.2014. Crucially, it concludes by mentioning that the Supervisory Board will determine proposals related to holding the General Assembly ('Glavne skupštine') once the Management Board sets the date. Because this document summarizes annual results but is very brief and focuses on the approval of the statements and the upcoming AGM, it functions primarily as an initial announcement of results rather than the full Annual Report (10-K) or a comprehensive Interim Report (IR). It contains key highlights typical of an Earnings Release (ER). However, since it specifically mentions the approval of the full-year financial statements (which usually precedes the formal 10-K filing or is part of the Annual Report package), and it is a concise summary, it aligns best with the Earnings Release (ER) definition, which covers initial announcements of periodical financial results (key highlights only). Given the context of annual results being approved, ER is the most appropriate fit among the options for a short summary announcement. FY 2014
2015-03-10 Croatian
Obavijest o stjecanju dionica - Jasminko Herceg
Director's Dealing Classification · 98% confidence The document title is "OBAVIJEST O STJECANJU DIONICA" which translates to "NOTICE OF ACQUISITION OF SHARES". The text explicitly states that a member of the Management Board (Jasminko Herceg) acquired 120 shares of Medika d.d. based on a Share Transfer Agreement. This directly relates to personal share transactions by a director/executive, which corresponds to the Director's Dealing (DIRS) category. Although it involves share acquisition, the context is an insider transaction report, not a general capital change (SHA) or a company buying back its own shares (POS). Given the explicit mention of a director acquiring shares, DIRS is the most appropriate classification.
2015-03-10 Croatian

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.